Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently spreading rapidly around the globe, causing a major public health issue. There is currently very few data about the impact of COVID-19 on pregnancy, and potential in utero infection. This is a prospective observational study of COVID-19 diagnosed pregnant patients. This objective is to examine the impact of COVID-19 during pregnancy on the rates of obstetric and perinatal complications.
Clinical manifestations of COVID-19 can range from a benign upper respiratory tract infection
to severe acute respiratory distress syndrome (ARDS), fatal in 1% of cases. However, pregnant
women and their fetuses could particularly be vulnerable to the infection, as shown by
previous human coronavirus outbreaks (SARS-CoV and MERS-CoV).
Cases will be recruited among all pregnant women aged >18 years old who have tested positive
for COVID-19 and are followed in a maternity belonging to the French South Regional
Perinatology Network. Voluntary physicians will refer eligible participants to the
study-coordinating center at APHM University Hospital. The participants will be followed by
phone after having provided an informed consent. Clinical symptoms, laboratory and imaging
findings, maternal and perinatal outcomes will be recorded.
Behavioral: Examine the impact of COVID-19 during pregnancy
clinical data collection
Inclusion Criteria:
- Pregnant women
- Able to give informed consent
- Diagnosed with COVID-19
Exclusion Criteria:
- Patients Refusing to Participate in the Study
- Patients who do not speak French well enough to benefit from clear and intelligible
information
Assistance Publique Hôpitaux de Marseille
Marseille, Paca, France
Jean-Olivier ARNAUD, Director, Study Director
Assistance Publique Hôpitaux de Marseille